Search results
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 17 hours agoInc (NASDAQ:VIR) has a robust financial position with $1.51 billion in cash, cash equivalents, and investments, providing flexibility for future investments and program funding. The company ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 5 hours agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Q1 2024 Vir Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 15 hours agoWith that, I'll turn the call over to Carey. Thank you, Maria. Carey Hwang I'll begin by reminding you about the initial results from our Phase two psoriasis trial on hepatitis ...
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via Yahoo News· 4 days agoResearch shows that certain oils may boost blood circulation, which in turn may stimulate scalp hair...
Ashley Judd on the New White House Plan to Prevent Suicide
The Oprah Magazine via Yahoo News· 3 days agoThat understanding informs our feelings, and how we feel about someone creates how we treat them....
Digital Health Sector Slowed Down in 2023
Medscape· 20 hours agoAlthough the average amount raised in European funding rounds decreased, the number of investors increased by nearly one quarter.
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 2 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Change Eligibility Rules for More Diverse Clinical Trials?
Medscape· 20 hours agoExpanding eligibility criteria is a strategy for improving the inclusion of traditionally...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
FOX 59 Indianapolis· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Children With Chronic Skin Disorders Face Substantial Stigma
Medscape· 5 days agoHealthcare professionals should be aware of the possibility of stigmatization and bullying when...
